AZNCF - AstraZeneca PLC

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
3,288,000
3,288,000
112,000
3,196,000
1,335,000
Depreciation & amortization
5,254,000
5,480,000
6,530,000
3,149,000
3,762,000
Change in working capital
3,757,000
3,757,000
2,021,000
361,000
-346,000
Inventory
3,941,000
3,941,000
1,577,000
-621,000
-316,000
Other working capital
7,237,000
7,237,000
3,763,000
2,193,000
509,000
Other non-cash items
625,000
641,000
1,366,000
671,000
1,024,000
Net cash provided by operating activites
9,808,000
9,808,000
5,963,000
4,799,000
2,969,000
Cash flows from investing activities
Investments in property, plant and equipment
-2,571,000
-2,571,000
-2,200,000
-2,606,000
-2,460,000
Acquisitions, net
-1,061,000
-1,061,000
-10,209,000
-830,000
-783,000
Purchases of investments
-159,000
-159,000
-184,000
-119,000
-13,000
Sales/Maturities of investments
42,000
42,000
105,000
2,126,000
212,000
Other investing activites
-
-
20,000
40,000
150,000
Net cash used for investing activites
-2,960,000
-2,960,000
-11,058,000
-285,000
-657,000
Net change in cash
25,000
25,000
-1,446,000
2,311,000
547,000
Cash at beginning of period
6,038,000
6,038,000
7,546,000
5,223,000
4,671,000
Cash at end of period
5,983,000
5,983,000
6,038,000
7,546,000
5,223,000
Free Cash Flow
Operating Cash Flow
9,808,000
9,808,000
5,963,000
4,799,000
2,969,000
Capital Expenditure
-2,571,000
-2,571,000
-2,200,000
-2,606,000
-2,460,000
Free Cash Flow
7,237,000
7,237,000
3,763,000
2,193,000
509,000